News
TipRanks on MSN20h
AbbVie’s Promising Study on Targeted Therapies for Crohn’s Disease
Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 2a multicenter study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback